🇺🇸 FDA
Patent

US 10947238

Wee1 kinase inhibitors and methods of making and using the same

granted A61KA61K31/519A61K31/5377

Quick answer

US patent 10947238 (Wee1 kinase inhibitors and methods of making and using the same) held by The Regents of the University of Colorado, a Body Corporate expires Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/519, A61K31/5377, A61K31/7068, A61K33/243